By PTI Jan 8, 2020 9:52:29 PM IST (Published)
Drug firm Strides Pharma Science on Wednesday said it's board has appointed R Ananthanarayanan as chief executive officer and managing director of the company effective January 9.
Drug firm Strides Pharma Science on Wednesday said it's board has appointed R Ananthanarayanan as chief executive officer and managing director of the company effective January 9.
He will succeed Arun Kumar, founder and the incumbent CEO and MD of the company, Strides Pharma Science said in a statement.
"Arun will transition his active responsibilities at Strides by the financial year ending March 31, 2020, and will step into a strategic role as chairman of the board with effect from April 1, 2020," it added.